pf-05190457
Showing 1 - 4 of 4
Alcoholism Trial run by the NIAAA (PF-05190457, Placebo)
Terminated
- Alcoholism
- PF-05190457
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 23, 2022
Alcoholism, Alcohol-Related Disorders, Alcohol Dependence Trial run by the NIAAA (PF-05190457)
Completed
- Alcoholism
- +4 more
- PF-05190457
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019
Diabetes, Type 2 Trial in Singapore (PF-05190457)
Completed
- Diabetes Mellitus, Type 2
- PF-05190457
-
Singapore, SingaporePfizer Investigational Site
Jan 27, 2012
Diabetes, Type II Trial in Bruxelles (PF-05190457, Placebo)
Completed
- Diabetes Mellitus, Type II
- PF-05190457
- Placebo
-
Bruxelles, BelgiumPfizer Investigational Site
Jul 5, 2011